ArticleISRN AIDS2013

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy.

Christos Tsoukas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.